Evidence map›Paper›PMID 38660122›Full record

ReviewClinical kidney journal2024

Kidney involvement in Wilson's disease: a review of the literature.

Julien Dang, Kevin Chevalier, Emmanuel Letavernier, Come Tissandier, Sarah Mouawad, Dominique Debray, Mickaël Obadia, Aurélia Poujois

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Clinical kidney journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07765472 (Assessment of Subtle Myocardial Dysfunction in Children With Wilson's Disease), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07765472 active not recruitingnot on this mapstarted 2025, after this paper: background citation

Assessment of Subtle Myocardial Dysfunction in Children With Wilson's Disease: A Case-Control Study

TypeobservationalSponsorHebatullah FawzyRan2025 to 2026Enrolled72ConditionsWilson's Disease, Myocardial Dysfunction, Children, Wilson DiseaseArmsEchocardiography, Electrocardiography, N-terminal pro b- type natriuretic peptide
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. A diagnostic dilemma in a child with Wilson's disease.Pediatric nephrology (Berlin, Germany) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Analyses ofHuman mutation · 2026
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Renal Impairment in Wilson's Disease.Kidney international reports · 2025
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Julien DangAssistance Publique des Hôpitaux de Paris (AP-HP), Université Paris-Saclay, Hôpital de Bicêtre, Service de Néphrologie et Transplantation, Le Kremlin-Bicêtre, France.
Kevin ChevalierHôpital Fondation Rothschild, Service de Neurologie, Paris, France.
Emmanuel LetavernierAP-HP, Hôpital Tenon, Service des Explorations Fonctionnelles Multidisciplinaires, Paris, France.
Come TissandierAssistance Publique des Hôpitaux de Paris (AP-HP), Université Paris-Saclay, Hôpital de Bicêtre, Service de Néphrologie et Transplantation, Le Kremlin-Bicêtre, France.
Sarah MouawadAssistance Publique des Hôpitaux de Paris (AP-HP), Université Paris-Saclay, Hôpital de Bicêtre, Service de Néphrologie et Transplantation, Le Kremlin-Bicêtre, France.
Dominique DebrayHôpital Fondation Rothschild, Service de Neurologie, Paris, France.
Mickaël ObadiaHôpital Fondation Rothschild, Service de Neurologie, Paris, France.
Aurélia PoujoisHôpital Fondation Rothschild, Service de Neurologie, Paris, France.
Fondation de Rothschild · FRBicêtre Hospital · FRAssistance Publique – Hôpitaux de Paris · FRHôpital Tenon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wilson's disease (WD) is a rare inherited disease due to the mutation of the ATP7B gene, resulting in impaired hepatic copper excretion and its pathological accumulation in various organs such as the liver, the nervous system, or the kidneys. Whereas liver failure and neuropsychiatric disorders are the most common features, less is known about the renal complications. We conducted a review of the literature to define the characteristics and pathophysiology of kidney involvement during WD. This review shed light on strong evidence for direct copper toxicity to renal tubular cells. Excessive tubular copper accumulation might present with various degrees of tubular dysfunction, ranging from mild hydroelectrolytic and acid-base disorders to complete Fanconi syndrome. Proximal and distal renal tubular acidosis also favors development of nephrolithiasis, nephrocalcinosis, and bone metabolism abnormalities. Indirect complications might involve renal hypoperfusion as occurs in hepatorenal or cardiorenal syndrome, but also tubular casts' formation during acute hemolysis, rhabdomyolysis, or bile cast nephropathy. Acute kidney failure is not uncommon in severe WD patients, and independently increases mortality. Finally, specific and long-term therapy by D-penicillamin, one of the most efficient drugs in WD, can cause glomerular injuries, such as membranous nephropathy, minimal-change disease, and, rarely, severe glomerulonephritis. Altogether, our study supports the need for interdisciplinary evaluation of WD patients involving nephrologists, with regular monitoring of tubular and glomerular functions, to provide adequate prevention of renal and bone involvement.

Indexed as

Fanconi syndromehypercalciurianephrolithiasisrenal acidosisWilson's disease

Identifiers

PMID38660122
PMCPMC11040517
OpenAlexW4392627761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.